Massachusetts Financial Services’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-194,969
Closed -$11.7M 922
2020
Q2
$11.7M Buy
194,969
+9,313
+5% +$575K ﹤0.01% 595
2020
Q1
$11M Sell
185,656
-83,265
-31% -$4.85M 0.01% 578
2019
Q4
$14.7M Buy
268,921
+82
+0% +$3.06K 0.01% 563
2019
Q3
$7.59M Sell
268,839
-1,011
-0.4% -$37.1K ﹤0.01% 629
2019
Q2
$8.96M Buy
269,850
+39,594
+17% +$1.24M ﹤0.01% 634
2019
Q1
$7.83M Sell
230,256
-150
-0.1% -$4.77K ﹤0.01% 632
2018
Q4
$6.31M Buy
230,406
+4,844
+2% +$125K ﹤0.01% 647
2018
Q3
$6.59M Buy
+225,562
New +$6.37M ﹤0.01% 662

Other funds holding PRNB

Massachusetts Financial Services's PRNB Position: Q3 2020 in Review

Massachusetts Financial Services sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 194,969 shares — an estimated $11.7M sold.

Massachusetts Financial Services first reported a position in PRNB in Q3 2018 and held it in 8 quarters. The position peaked at $14.7M in Q4 2019. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

  • Massachusetts Financial Services reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Massachusetts Financial Services sold 194,969 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $11.7M.
  • Massachusetts Financial Services first reported a position in Principia Biopharma Inc. Common Stock in Q3 2018 and held it in 8 quarters.
  • Massachusetts Financial Services's Principia Biopharma Inc. Common Stock position peaked at $14.7M in Q4 2019.
  • 9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Massachusetts Financial Services's 13F filing for Q3 2020, filed 12 Nov 2020.